Jon Jones is once again making headlines for all the wrong reasons, failing a USADA drug test (again) the day before his UFC 214 light heavyweight title fight with Daniel Cormier. The news of the drug violation was revealed by TMZ along with a claim that Jones’ title would be handed back to Cormier. Since then we've learned that Jones hasn't been formally stripped (yet), and now we have this statement directly from UFC:
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Jon Jones of a potential Anti-Doping Policy violation stemming from an in-competition sample collected following his weigh-in on July 28, 2017.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Jones, as it relates to the UFC Anti-Doping Policy and future UFC participation. Under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed.
The California State Athletic Commission (CSAC) also retains jurisdiction over this matter as the sample collection was performed the day before Jones’ bout at UFC 214 in Anaheim, CA, and USADA will work to ensure that the CSAC has the necessary information to determine its proper judgment of Jones’ potential anti-doping violation.
Additional information will be provided at the appropriate time as the process moves forward.
Jones had just gotten back from a one-year suspension following UFC 200 for estrogen blockers. This time the drug in question is allegedly turinabol, an anabolic steroid. With this being his second drug failure under USADA’s program, he's facing up to four years in suspension time.
And no story about tainted “dick pills” is going to help shorten things.